Department of Nuclear Medicine, Shiraz Medical Center, Shiraz, Iran
Abstract
Scientimammography (SMM) is a new non-invasive method of imaging breast tumors which in various studies the overall sensitivity of 83%-95.8% and specificity of 52%-95% is reported. The purpose of our study was to evaluate the usefullness of 99mTc-MIBI SMM in our environment in detecting breast cancer and in reducing the rate of biopsy. 65 patients aged 23-70 years were included in this study. The overall sensitivity and specificity of SMM were 84.6% and 71.8% respectively. The PPV of 66.6% and NPV of 87.5% were similar to that obtained by others. These results showed that, SMM did not increase the specificity and PPV of mammography. However SMM is a useful method for evaluating patients with low suspicion or indeterminate mammographic or palpable findings or lesions larger than 1.5 cm.
Falamaki, M., Ghadimi Mahani, M., Alavi, M., Talei, A. & Rasekhi, A. (2002). The role of 99mTc-MIBI scientimammography in diagnosis of breast cancer. Iranian Journal of Nuclear Medicine, 10(2), 7–13.
MLA
Falamaki, M., Ghadimi Mahani, M., Alavi, M., Talei, A., & Rasekhi, A. "The role of 99mTc-MIBI scientimammography in diagnosis of breast cancer", Iranian Journal of Nuclear Medicine, 10, 2, 2002, 7–13.
HARVARD
Falamaki, M., Ghadimi Mahani, M., Alavi, M., Talei, A., & Rasekhi, A. (2002). 'The role of 99mTc-MIBI scientimammography in diagnosis of breast cancer', Iranian Journal of Nuclear Medicine, 10(2), pp. 7–13.
CHICAGO
Falamaki, M., Ghadimi Mahani, M., Alavi, M., Talei, A. & Rasekhi, A., "The role of 99mTc-MIBI scientimammography in diagnosis of breast cancer." Iranian Journal of Nuclear Medicine, 10 2 (2002): 7–13,
VANCOUVER
Falamaki M., Ghadimi Mahani M., Alavi M., Talei A., Rasekhi A. The role of 99mTc-MIBI scientimammography in diagnosis of breast cancer. Iran J Nucl Med. 2002;10(2):7–13.